Referências
Principais artigos
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 Aug 20;140(8):e382-482.Texto completo Resumo
Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Heart Rhythm. 2012 Oct;9(10):1737-53.Texto completo Resumo
Glikson M, Nielsen JC, Kronborg MB, et al; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 Sep 14;42(35):3427-520.Texto completo Resumo
Artigos de referência
1. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 Aug 20;140(8):e382-482.Texto completo Resumo
2. Cheng S, Keyes MJ, Larson MG, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009 Jun 24;301(24):2571-7.Texto completo Resumo
3. Upshaw CB Jr. Comparison of the prevalence of first-degree atrioventricular block in African-American and in Caucasian patients: an electrocardiographic study III. J Natl Med Assoc. 2004 Jun;96(6):756-60.Texto completo Resumo
4. DePaula RS, Antelmi I, Vincenzi MA, et al. Cardiac arrhythmias and atrioventricular block in a cohort of asymptomatic individuals without heart disease. Cardiology. 2007;108:111-116. Resumo
5. Du Z, Xing L, Lin M, et al. Prevalence of first-degree atrioventricular block and the associated risk factors: a cross-sectional study in rural Northeast China. BMC Cardiovasc Disord. 2019 Oct 7;19(1):214.Texto completo Resumo
6. Kerola T, Eranti A, Aro AL, et al. Risk factors associated with atrioventricular block. JAMA Netw Open. 2019 May 3;2(5):e194176.Texto completo Resumo
7. Kwok CS, Rashid M, Beynon R, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016 May;102(9):672-80.Texto completo Resumo
8. Kreger BE, Anderson KM, Kannel WB. Prevalence of intraventricular block in the general population: the Framingham Study. Am Heart J. 1989 Apr;117(4):903-10. Resumo
9. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest. 2005;128:30-5. Resumo
10. Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020 Oct 13;142(15):e214-33.Texto completo Resumo
11. Deisenhofer I, Zrenner B, Yin YH, et al. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation. 2010 Nov 30;122(22):2239-45.Texto completo Resumo
12. Ali H, Furlanello F, Lupo P, et al. Clinical and electrocardiographic features of complete heart block after blunt cardiac injury: a systematic review of the literature. Heart Rhythm. 2017 Jun 3;14(10):1561-9. Resumo
13. Silici S, Atayoglu AT. Mad honey intoxication: A systematic review on the 1199 cases. Food Chem Toxicol. 2015 Nov 10;86:282-90. Resumo
14. Royer A, van Veen TA, Le Bouter S, et al. Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005 Apr 12;111(14):1738-46.Texto completo Resumo
15. Baruteau AE, Pass RH, Thambo JB, et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr. 2016 Sep;175(9):1235-48.Texto completo Resumo
16. Rudbeck-Resdal J, Christiansen MK, Johansen JB, et al. Aetiologies and temporal trends of atrioventricular block in young patients: a 20-year nationwide study. Europace. 2019 Nov 1;21(11):1710-6.Texto completo Resumo
17. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Heart Rhythm. 2012 Oct;9(10):1737-53.Texto completo Resumo
18. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis. 1964 Mar;6:409-44. Resumo
19. Lev M. Anatomic basis for atrioventricular block. Am J Med. 1964 Nov;37:742-8. Resumo
20. Zoob M, Smith KS. The aetiology of complete heart-block. Br Med J. 1963 Nov 9;2(5366):1149-53.Texto completo Resumo
21. Glikson M, Nielsen JC, Kronborg MB, et al; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 Sep 14;42(35):3427-520.Texto completo Resumo
22. Simon AB, Steinke WE, Curry JJ. Atrioventricular block in acute myocardial infarction. Chest. 1972 Aug;62(2):156-61. Resumo
23. Ruiz-Bailén M, Pola Gallego MD, Expósito Ruiz M, et al. Atrioventricular block in unstable angina: results of the ARIAM registry [in Spanish]. Med Intensiva. 2006 Dec;30(9):432-9. Resumo
24. Hreybe H, Saba S. Location of acute myocardial infarction and associated arrhythmias and outcome. Clin Cardiol. 2009 May;32(5):274-7.Texto completo Resumo
25. Amsterdam EA, Wenger NK, Brindis RG, et al; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23;130(25):e344-426.Texto completo Resumo
26. Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015 Feb 17;131(7):624-32.Texto completo Resumo
27. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004 Nov;83(6):315-34. Resumo
28. Nordenswan HK, Lehtonen J, Ekström K, et al. Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block. Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006145.Texto completo Resumo
29. Salama A, Abdullah A, Nadkarni A, et al. Sarcoidosis increases the risk of complete heart block: a review from the national inpatient sample. J Am Coll Cardiol. 2019 Mar;73(9 Suppl 1):543.Texto completo
30. Kandolin R, Lehtonen J, Salmenkivi K, et al. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail. 2013 Jan;6(1):15-22.Texto completo Resumo
31. Matsumoto Y, Kubo T, Tagawa H, et al. An autopsy case of the sinus of Valsalva aneurysm involved with tuberculous inflammation, leading to complete heart block. [in jpn]. Kokyu To Junkan. 1993 Sep;41(9):911-5. Resumo
32. Yang KC, Hung CC, Ho YL. Tuberculous serositis coexisting with reversible high-grade atrioventricular block. Acta Cardiol Sin. 2005;21:164-8.Texto completo
33. Robinson ML, Kobayashi T, Higgins Y, et al. Lyme carditis. Infect Dis Clin North Am. 2015 Jun;29(2):255-68.Texto completo Resumo
34. Puech P, Grolleau R, Buimond C. Incidence of different types of A-V block and their localization by His bundle recordings. In: Wellens HJ, Lie KI, Janse MJ, eds. The conduction system of the heart: structure, function, and clinical implications. Philadelphia, PA: Lea & Febiger; 1976:467-84.
35. Fenton AM, Hammill SC, Rea RF, et al. Vasovagal syncope. Ann Intern Med. 2000;133:714-725. Resumo
36. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol. 2006:47:1927-37.Texto completo Resumo
37. Funck RC, Blanc JJ, Mueller HH, et al; BioPace Study Group. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. Europace. 2006;8:629-35.Texto completo Resumo
38. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-726.Texto completo Resumo
39. Sumiyoshi M, Nakata Y, Yasuda M, et al. Changes of conductivity in patients with second- or third-degree atrioventricular block after pacemaker implantation. Jpn Circ J. 1995;59:284-91. Resumo
40. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e895-1032.Texto completo Resumo
41. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706-13.Texto completo Resumo
42. Farraha M, Kumar S, Chong J, et al. Gene therapy approaches to biological pacemakers. J Cardiovasc Dev Dis. 2018 Oct 19;5(4):50.Texto completo Resumo
43. Goto H, Sugiura T, Harada Y, et al. Feasibility of using the automatic generating system for quartz watches as a leadless pacemaker power source. Med Biol Eng Comput. 1999;37:377-80. Resumo
44. Lee KL, Tse HF, Echt DS, et al. Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window. Heart Rhythm. 2009;6:742-8. Resumo
45. Lee KL, Lau CP, Tse HF, et al. First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. J Am Coll Cardiol. 2007;50:877-83.Texto completo Resumo
46. Echt DS, Cowan MW, Riley RE, et al. Feasibility and safety of a novel technology for pacing without leads. Heart Rhythm. 2006;3:1202-6. Resumo
47. Reddy VY, Exner DV, Cantillon DJ, et al.; LEADLESS II Study Investigators. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125-35.Texto completo Resumo
48. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996;100:290-8. Resumo
49. Santangeli P, Ferrante G, Pelargonio G, et al. Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review. Europace. 2010;12:649-54. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal